Cargando…

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer

BACKGROUND: Host genetic factors might affect the risk of progression from infection with carcinogenic human papillomavirus (HPV), the etiologic agent for cervical cancer, to persistent HPV infection, and hence to cervical precancer and cancer. METHODOLOGY/PRINCIPAL FINDINGS: We assessed 18,310 tag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safaeian, Mahboobeh, Hildesheim, Allan, Gonzalez, Paula, Yu, Kai, Porras, Carolina, Li, Qizhai, Rodriguez, Ana Cecilia, Sherman, Mark E., Schiffman, Mark, Wacholder, Sholom, Burk, Robert, Herrero, Rolando, Burdette, Laurie, Chanock, Stephen J., Wang, Sophia S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322120/ https://www.ncbi.nlm.nih.gov/pubmed/22496757 http://dx.doi.org/10.1371/journal.pone.0033619

Ejemplares similares

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
por: Wang, Sophia S., et al.
Publicado: (2010)

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
por: Castle, Philip E, et al.
Publicado: (2009)

Determinants of seropositivity among HPV-16/18 DNA positive young women
por: Porras, Carolina, et al.
Publicado: (2010)

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
por: Lin, Shih-Wen, et al.
Publicado: (2013)

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
por: Clarke, Megan A, et al.
Publicado: (2012)

Cervicovaginal microbiome and natural history of HPV in a longitudinal study
por: Usyk, Mykhaylo, et al.
Publicado: (2020)

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
por: Hildesheim, Allan, et al.
Publicado: (2016)

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
por: Kreimer, Aimée R., et al.
Publicado: (2011)

Sequence Imputation of HPV16 Genomes for Genetic Association Studies
por: Smith, Benjamin, et al.
Publicado: (2011)

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays
por: Robbins, Hilary A., et al.
Publicado: (2014)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013)

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
por: Kreimer, Aimée R., et al.
Publicado: (2018)

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica
por: Clarke, Megan, et al.
Publicado: (2013)

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
por: Robbins, Hilary A, et al.
Publicado: (2014)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Population Substructure and Control Selection in Genome-Wide Association Studies
por: Yu, Kai, et al.
Publicado: (2008)

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
por: Cullen, Michael, et al.
Publicado: (2015)

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
por: Hildesheim, A, et al.
Publicado: (2001)

T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study
por: Lang Kuhs, Krystle A., et al.
Publicado: (2018)

Genetic Admixture and Population Substructure in Guanacaste Costa Rica
por: Wang, Zhaoming, et al.
Publicado: (2010)

Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women
por: Anastos, Kathryn, et al.
Publicado: (2010)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria
por: Clarke, Megan A, et al.
Publicado: (2011)

Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels
por: Kemp, Troy J., et al.
Publicado: (2012)

Searching HPV genome for methylation sites involved in molecular progression to cervical precancer
por: Kottaridi, Christine, et al.
Publicado: (2019)

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)

A case–control study of endogenous hormones and cervical cancer
por: Shields, T S, et al.
Publicado: (2004)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy
por: Demarco, Maria, et al.
Publicado: (2018)

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping
por: Hernández-López, Rubí, et al.
Publicado: (2019)

Ensemble Deep Learning for Cervix Image Selection toward Improving Reliability in Automated Cervical Precancer Screening
por: Guo, Peng, et al.
Publicado: (2020)

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
por: Mirabello, Lisa, et al.
Publicado: (2018)

Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial
por: Sierra, Mónica S., et al.
Publicado: (2023)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation
por: Lou, Hong, et al.
Publicado: (2022)

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history
por: Usyk, Mykhaylo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tanbkef8kul0q5urrc4f9r2itn